WallStreetZenWallStreetZen

NASDAQ: BSGM
Biosig Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BSGM

Based on 1 analyst offering 12 month price targets for Biosig Technologies Inc

Min Forecast
$10.00+3.63%
Avg Forecast
$10.00+3.63%
Max Forecast
$10.00+3.63%

Should I buy or sell BSGM stock?

Based on 1 analyst offering ratings for Biosig Technologies Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BSGM's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BSGM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BSGM stock forecasts and price targets.

BSGM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-06

1 of 1

Forecast return on equity

Is BSGM forecast to generate an efficient return?

Company
N/A
Industry
22.93%
Market
67.05%

Forecast return on assets

Is BSGM forecast to generate an efficient return on assets?

Company
N/A
Industry
12.07%

BSGM earnings per share forecast

What is BSGM's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.25
Avg 2 year Forecast
-$0.17

BSGM revenue forecast

What is BSGM's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$300.0k+1,053.85%
BSGM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BSGM revenue growth forecast

How is BSGM forecast to perform vs Medical Devices companies and vs the US market?

Company
369.86%
Industry
8.23%
Market
10.32%
BSGM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BSGM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BSGM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BSGM$9.65$10.00+3.63%Buy
PTHL$18.38N/AN/A
QTRX$6.92$12.67+83.05%Buy
SNWV$31.72N/AN/A
CATX$3.39$12.43+266.64%Strong Buy
View Top Medical Device Stocks

Biosig Technologies Stock Forecast FAQ

Is Biosig Technologies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BSGM) stock is to Buy BSGM stock.

Out of 1 analyst, 0 (0%) are recommending BSGM as a Strong Buy, 1 (100%) are recommending BSGM as a Buy, 0 (0%) are recommending BSGM as a Hold, 0 (0%) are recommending BSGM as a Sell, and 0 (0%) are recommending BSGM as a Strong Sell.

If you're new to stock investing, here's how to buy Biosig Technologies stock.

What is BSGM's earnings growth forecast for 2025-2026?

(NASDAQ: BSGM) Biosig Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 20.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.04%.

Biosig Technologies's earnings in 2025 is -$9,790,000.On average, 1 Wall Street analyst forecast BSGM's earnings for 2025 to be -$6,823,651, with the lowest BSGM earnings forecast at -$6,823,651, and the highest BSGM earnings forecast at -$6,823,651.

In 2026, BSGM is forecast to generate -$4,640,083 in earnings, with the lowest earnings forecast at -$4,640,083 and the highest earnings forecast at -$4,640,083.

What is BSGM's revenue growth forecast for 2025-2025?

(NASDAQ: BSGM) Biosig Technologies's forecast annual revenue growth rate of 369.86% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.23%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.32%.

Biosig Technologies's revenue in 2025 is $26,000.

In 2025, BSGM is forecast to generate $8,188,381 in revenue, with the lowest revenue forecast at $8,188,381 and the highest revenue forecast at $8,188,381.

What is BSGM's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: BSGM) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.07%.

What is BSGM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BSGM price target, the average BSGM price target is $10.00, with the highest BSGM stock price forecast at $10.00 and the lowest BSGM stock price forecast at $10.00.

The Wall Street analyst predicted that Biosig Technologies's share price could reach $10.00 by Jun 6, 2026. The average Biosig Technologies stock price prediction forecasts a potential upside of 3.63% from the current BSGM share price of $9.65.

What is BSGM's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: BSGM) Biosig Technologies's current Earnings Per Share (EPS) is -$0.59. On average, analysts forecast that BSGM's EPS will be -$0.25 for 2025, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.25. In 2026, BSGM's EPS is forecast to hit -$0.17 (min: -$0.17, max: -$0.17).

What is BSGM's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: BSGM) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.